SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-16-016382
Filing Date
2016-10-28
Accepted
2016-10-28 17:21:36
Documents
2
Period of Report
2016-12-14
Effectiveness Date
2016-10-28

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2230125zdef14a.htm DEF 14A 270108
2 G95000.JPG g95000.jpg GRAPHIC 17176
  Complete submission text file 0001047469-16-016382.txt   294957
Mailing Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837
Business Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837 732-902-4000
ContraVir Pharmaceuticals, Inc. (Filer) CIK: 0001583771 (see all company filings)

IRS No.: 462783806 | State of Incorp.: DE | Fiscal Year End: 0630
Type: DEF 14A | Act: 34 | File No.: 001-36856 | Film No.: 161959514
SIC: 2834 Pharmaceutical Preparations